Sleep and daily functioning during androgen deprivation therapy for prostate cancer
- 6 September 2010
- journal article
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 20 (4), 549-554
- https://doi.org/10.1111/j.1365-2354.2010.01226.x
Abstract
HANISCH L.J., GOONERATNE N.S., SOIN K., GEHRMAN P.R., VAUGHN D.J. & COYNE J.C. (2010) European Journal of Cancer CareSleep and daily functioning during androgen deprivation therapy for prostate cancer A limited body of evidence suggests that sleep problems are common in prostate cancer patients undergoing androgen deprivation therapy, yet little is known about sleep characteristics and the effects of poor sleep on daily functioning in this population. This study assessed sleep in 60 prostate cancer patients taking androgen deprivation therapy with wrist actigraphy and daily diaries for 7 days. The Epworth Sleepiness Scale and the general version of the Functional Assessment of Cancer Therapy scale were also administered. On average, total sleep time was 5.9 (SD = 1.4) h, and sleep efficiency was 75% (SD = 12.0) as assessed by actigraphy. There was generally poor concordance between actigraphy and daily diary for most sleep metrics. Subjects reported awakening, on average, 2.7 times per night, most commonly for nocturia and hot flashes. Assessment of daily functioning showed that participants had mild daytime sleepiness, which was predicted by total sleep time (F(1,47) = 4.5, P= 0.04) General quality of life was not impaired. This study supports more research on the predictors of poor sleep in order to identify effective interventions.Keywords
This publication has 29 references indexed in Scilit:
- An international survey of sleeping problems in the general populationCurrent Medical Research and Opinion, 2007
- Comorbidity of Chronic Insomnia With Medical ProblemsSleep, 2007
- Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate CancerJournal of Urology, 2006
- The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)BJU International, 2006
- Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapyJournal of Rehabilitation Research and Development, 2005
- Insomnia in men treated with radical prostatectomy for prostate cancerPsycho‐Oncology, 2004
- Insomnia as a Health Risk FactorBehavioral Sleep Medicine, 2003
- Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II.1999
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.Journal of Clinical Oncology, 1993
- Reliability and Factor Analysis of the Epworth Sleepiness ScaleSleep, 1992